AREG is co-expressed with AR in invasive breast cancer, which is reported as one of the prognostic biomarkers and therapeutic targets in invasive breast cancer, particularly in ER-negative breast cancer (MCF-7). This evidence concerns the gene AREG and invasive breast carcinoma.